Modern research
The extract from white peony root may have a beneficial effect on
IgA nephropathy.
Paeonol (2'-hydroxy-4'-methoxyacetophenone), the main active compound of white
peony root, has anti-inflammatory, antioxidant and cardiovascular protective
activities. Other substances in this herb include paeoniflorin and albiflorin.
Subscribe
to a
FREE
Supplement
Research Update newsletter. Twice a month we email a brief abstract
of several studies on various supplements and natural medicine topics, including
white peony root, and
their practical interpretation by Ray Sahelian, M.D.
For a list of herbs used in Chinese medicine, see Chinese Herbs.
White Peony Root Research Update
The effect of the extract from Radix Paeoniae alba on
IgA Glomerulonephritis in mice
Zhong Yao Cai. 2003 Feb;26(2):109-11.
To observe the effect of the extract from Radix Paeoniae Alba on IgA
glomerulonephritis in mice. METHODS: IgA glomerulonephritis was induced by
injection of dextran and sephadex-150. After administrating the extract,
the contents of urinary protein, BUN and Cr in serum were determined.
RESULTS: The extract could inhibit the decline of mouse weight, and
decrease urinary protein content and BUN content in serum. While, the
extract had no effect on Cr in serum. The extract from white
peony root had therapeutical effect on IgA glomerulonephritis.
Clinical and experimental study of shenshao tongguan pian
in treating angina pectoris of coronary heart disease
Zhong Xi Yi Jie He Za Zhi. 1990 Oct;10(10):596-9, 580.
Shenshao Tongguan Pian (SSTGP) is composed chiefly of saponins from the
stem and leaf of Ginseng and Radix Paeoniae Alba, etc. The authors applied
this remedy for the treatment of angina pectoris of CHD. From 1982-1988,
the authors carried out a randomized double blind trial on altogether 565
cases of CHD divided into an experimental group to be treated with SSTGP
and a control group treated with another TCM proprietory medicine, Dan Qi
Pian, that had been used for many years clinically. The total effective
rate of treating angina pectoris was 94.71% and ECG improvement rate
63.38% in experimental group whereas 66.99% and 23.38% respectively in the
control group, the difference being very significant (P less than 0.01).
Experiments with animals proved that SSTGP had more potent actions on CV
system, such as dilatation of coronary arteries, promotion of coronary
perfusion flow, lowering oxygen consumption of heart muscle, resisting the
coronary spasm, anoxia and ischemia of heart muscle elicited by pituitrin,
and prolongation of survival time of mice under anoxic state. In addition,
laboratory examination also revealed SSTGP could promote the left
ventricular output, lower the blood viscosity and inhibit the aggregation
of blood platelets. Both acute and chronic toxicity tests showed SSTGP has
no toxicity nor side effects. Therefore SSTGP is a new, safe and effective
TCM proprietory remedy for CHD and angina pectoris.
Clinical study of 96 cases with chronic hepatitis B treated with jiedu
yanggan gao by a double-blind method
Zhong Xi Yi Jie He Za Zhi. 1990 Feb;10(2):71-4, 67.
This paper reported 96 cases with chronic hepatitis B treated by a
double-blind method. There were 51 cases of observation group (OG) and 45
cases of control group (CG). OG was treated with Jiedu Yanggan Gao
consisting of Artemisia capillaris, Taraxacum mongolicum, Plantago seed,
Cephalanoplos segetum, Hedyotis diffusa, Flos Chrysanthemi Indici, Smilax
glabra, Astragalus membranaceus, Salviae miltiorrhizae, Fructus Polygonii
Orientalis, Radix Paeoniae Alba, Polygonatum sibiricum, etc.). CG was
prescribed with three charred medicinal herbs (charred Fructus Crataegi,
charred Fructrus Hordei Germinatus, charred fermented mixture of several
medical herbs and wheat bran). The average duration of treatment was five
months. All 96 cases belong to the virus-duplication-type with positive
HBsAg for over one year. Among them 65.5% of cases HBeAg, DNAP and HBV-DNA
were positive. 20.8% of cases were positive in two out of the above tests.
13 data were compared statistically between two groups, and proved to be
comparable (P greater than 0.05) before treatment. 27% and 66% of
cases' ALT, AST returned to normal respectively in OG after treatment.
However, in CG they were 9% and 22. TTT returned
to normal in 52% cases of OG and 44% in CG. 20%
cases HBeAg shifted to negative in OG, but 6.7% in CG. Cases with negative
DNAP in OG occupied 34%, but 10% in CG. 31% cases' HBV-DNA changed
to negative in OG, while 17% in CG. After comprehensive judgement, the
total effective rate was 74% in OG and 24% in CG respectively.. Eight cases were basically cured in OG and one case in CG.
After one year's follow-up, one recurred in eight patients of OG, however
the only one cured in CG still relapsed.